Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Chronic Cardiopulmonary Disease
1 other identifier
interventional
136
1 country
2
Brief Summary
The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease
Started Apr 2025
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedStudy Start
First participant enrolled
April 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
May 28, 2025
May 1, 2025
3.2 years
June 22, 2023
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in physical activity
Daily step counts will be measured as an objective proxy for physical activity using FitBit pedometers (FitBit Inspire 3)
baseline, months 3, 6, 12, and 15
Secondary Outcomes (9)
Change in self-efficacy
baseline, months 3, 6, 12, and 15
Change in intrinsic motivation
baseline, months 3, 6, 12, and 15
Qualitative inquiry
months 6 and 12
Change in disease-specific quality-of-life
baseline, months 3, 6, 12, and 15
Change in exercise engagement
baseline, months 3, 6, 12, and 15
- +4 more secondary outcomes
Study Arms (2)
Mindful Steps
EXPERIMENTALMulti-modal web intervention including: pedometer with individualized step-count goals, motivational and educational content, online community forum, mind-body videos (short themed clips that support walking, plus library of mind-body exercises), online group mind-body exercise classes, star incentive system; educational booklet
Usual Care
NO INTERVENTIONPragmatic usual care (standard care through participant's healthcare provider including pharmacological treatment and general advice for physical activity); educational booklet
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of COPD (defined as cigarette smoking history \> 10 pack-years, and either a ratio of FEV1 to forced vital capacity \< 0.70 or chest CT evidence of emphysema) OR clinical diagnosis of HF syndrome (with left ventricular systolic dysfunction or preserved ejection fraction and New York Heart Association Class 1-3)
- Medical clearance from provider to participate in an exercise program
- Have an active email account; access to a computer device (desktop, laptop, tablet, or smartphone that supports the Fitbit app).
You may not qualify if:
- COPD or HF exacerbation in the previous month
- Inability to ambulate
- Inability to collect at least 7 of 14 days of baseline step counts
- Current participation in a cardiac or pulmonary rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beth Israel Deaconess Medical Centerlead
- Brigham and Women's Hospitalcollaborator
- VA Boston Healthcare Systemcollaborator
- University of Michigancollaborator
Study Sites (2)
VA Boston
Boston, Massachusetts, 02132, United States
BIDMC
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Testing will be facilitated by study staff who are blinded to treatment assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Mind-Body Research, BIDMC General Medicine Division; Associate Professor of Medicine, Harvard Medical School
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 7, 2023
Study Start
April 28, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share